Showing results (61-70 of 134) with videos related to
Sort By:
Pageof 14
Molecular Metabolism|December 12, 2013
Peptide lipidation stabilizes structure to enhance biological functionBrian P Ward, Nickki L Ottaway, Diego Perez-Tilve, et al.Cell Metabolism|August 3, 2017
The Sustained Effects of a Dual GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 DiabetesJuan Pablo Frias, Edward J Bastyr, Louis Vignati, et al.Journal of Medicinal Chemistry|April 29, 2005
Discovery of a beta-MSH-derived MC-4R selective agonistJohn P Mayer, Hansen M Hsiung, David B Flora, et al.Neuropharmacology|April 5, 2019
GLP-1/dexamethasone inhibits food reward without inducing mood and memory deficits in miceLéa Décarie-Spain, Alexandre Fisette, Zhimeng Zhu, et al.Molecular Metabolism|April 17, 2026
GIPR:GCGR co-agonism restores normal weight in obese rodentsDiego Perez-Tilve, Fa Zhang, Yujin Zhang, et al.Frontiers in Endocrinology|March 18, 2022
Peptide Model of the Mutant Proinsulin Syndrome. II. Nascent Structure and Biological ImplicationsYanwu Yang, Michael D Glidden, Balamurugan Dhayalan, et al.Biochemistry|March 20, 2026
A High-Potency Protein That Normalizes Body Weight in DIO Mice through Triple Agonism at FGF21, GLP1, and GIP ReceptorsFlorence M Brunel, Sebastian D Parlee, Pengyun Li, et al.Diabetologia|December 21, 2014
GLP-1-oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) miceRobert W Schwenk, Christian Baumeier, Brian Finan, et al.Molecular Metabolism|May 3, 2017
Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female miceSigrid Jall, Stephan Sachs, Christoffer Clemmensen, et al.Analytical Chemistry|July 31, 2010
Combinatorial libraries of synthetic peptides as a model for shotgun proteomicsBrian C Bohrer, Yong Fuga Li, James P Reilly, et al.Pageof 14